{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:35:27Z","timestamp":1772584527444,"version":"3.50.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81760382"],"award-info":[{"award-number":["81760382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Early identification and disease monitoring are challenges facing rheumatologists in the management of rheumatoid arthritis (RA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We utilized enzyme-linked immunosorbent assay (ELISA) to determine 14-3-3\u03b7 and anticyclic citrullinated peptide antibody (anti-CCP) levels, with rheumatoid factor (RF) level detected by rate nephelometry. The diagnostic value of each index was determined via receiver operating characteristic (ROC) curve, and the association between 14-3-3\u03b7 and osteoporosis was assessed using multiple logistic regression analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Serum levels of 14-3-3\u03b7 were 3.26 ng per mL in patients with RA. These levels were helpful in identifying patients with the disease, with the area under the curve (AUC) being 0.879 and 0.853, respectively, from all healthy control individuals and patients with RA. Combining 14-3-3\u03b7 with RF or anti-CCP increased the diagnostic rate. Logistic regression analysis identified 14-3-3\u03b7 as an independent risk factor for RA-related osteoporosis (odds ratio [OR], 1.503; 95% confidence interval [CI], 1.116\u20132.025; P &amp;lt;.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Serum 14-3-3\u03b7 detection by itself or combined with other serum indices was helpful in differentiating patients with RA. Also, it was a promising biomarker for disease monitoring in RA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/labmed\/lmaa001","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T12:23:02Z","timestamp":1578572582000},"page":"529-539","source":"Crossref","is-referenced-by-count":13,"title":["14-3-3\u03b7 Protein in Rheumatoid Arthritis: Promising Diagnostic Marker and Independent Risk Factor for Osteoporosis"],"prefix":"10.1093","volume":"51","author":[{"given":"Tingting","family":"Zeng","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Tan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine in Jiangxi Province, Department of Clinical Laboratory, the Second Affiliated Hospital of Nanchang University, Nanchang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine in Jiangxi Province, Department of Clinical Laboratory, the Second Affiliated Hospital of Nanchang University, Nanchang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlin","family":"Yu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine in Jiangxi Province, Department of Clinical Laboratory, the Second Affiliated Hospital of Nanchang University, Nanchang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,2,20]]},"reference":[{"issue":"10055","key":"2020090103122322100_CIT0001","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet."},{"issue":"4","key":"2020090103122322100_CIT0002","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14656566.2015.997709","article-title":"Management of osteoporosis in rheumatoid arthritis patients","volume":"16","author":"Hoes","year":"2015","journal-title":"Expert Opin Pharmacother."},{"issue":"2","key":"2020090103122322100_CIT0003","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/s10165-008-0032-5","article-title":"Characteristics of fracture and related factors in patients with rheumatoid arthritis","volume":"18","author":"Nampei","year":"2008","journal-title":"Mod Rheumatol."},{"issue":"9","key":"2020090103122322100_CIT0004","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis."},{"issue":"9","key":"2020090103122322100_CIT0005","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/1756-185X.12552","article-title":"Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis","volume":"19","author":"Chang","year":"2016","journal-title":"Int J Rheum Dis."},{"issue":"8","key":"2020090103122322100_CIT0006","first-page":"1650","article-title":"Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation","volume":"34","author":"Kilani","year":"2007","journal-title":"J Rheumatol."},{"issue":"2","key":"2020090103122322100_CIT0007","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/ar4547","article-title":"14-3-3\u03b7 is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damage","volume":"16","author":"Maksymowych","year":"2014","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"2020090103122322100_CIT0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/ard.2007.084772","article-title":"EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT","volume":"68","author":"Zhang","year":"2009","journal-title":"Ann Rheum Dis."},{"issue":"6","key":"2020090103122322100_CIT0009","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"2020090103122322100_CIT0010","doi-asserted-by":"crossref","first-page":"c5623","DOI":"10.1136\/bmj.c5623","article-title":"Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidance","volume":"341","author":"Burden","year":"2010","journal-title":"BMJ."},{"issue":"8","key":"2020090103122322100_CIT0011","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"1","key":"2020090103122322100_CIT0012","first-page":"9","article-title":"American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"2020090103122322100_CIT0013","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"2020090103122322100_CIT0014","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48-49","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun."},{"key":"2020090103122322100_CIT0015","doi-asserted-by":"crossref","first-page":"504078","DOI":"10.4061\/2010\/504078","article-title":"Bone density and cortical thickness in normal, osteopenia, and osteoporotic sacra","volume":"2010","author":"Richards","year":"2010","journal-title":"J Osteoporos."},{"issue":"1","key":"2020090103122322100_CIT0016","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/oxfordjournals.epirev.a036058","article-title":"Epidemiology of rheumatoid arthritis: update","volume":"12","author":"Hochberg","year":"1990","journal-title":"Epidemiol Rev."},{"key":"2020090103122322100_CIT0017","first-page":"S128","article-title":"Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsis","volume":"20","author":"Gibofsky","year":"2014","journal-title":"Am J Manag Care."},{"issue":"23","key":"2020090103122322100_CIT0018","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med."},{"issue":"7","key":"2020090103122322100_CIT0019","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"2020090103122322100_CIT0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"2020090103122322100_CIT0021","first-page":"492","article-title":"EULAR recommendations for the managements of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Rheumatologia."},{"issue":"27-28","key":"2020090103122322100_CIT0022","first-page":"477","article-title":"Rheumatoid arthritis\u2013early diagnosis and disease management","volume":"110","author":"Schneider","year":"2013","journal-title":"Dtsch Arztebl Int."},{"issue":"2","key":"2020090103122322100_CIT0023","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3899\/jrheum.160693","article-title":"Disease characteristics and rheumatoid arthritis development in patients with early undifferentiated arthritis: a 2-year followup study","volume":"44","author":"Brinkmann","year":"2017","journal-title":"J Rheumatol."},{"issue":"1","key":"2020090103122322100_CIT0024","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tcb.2008.10.003","article-title":"The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development","volume":"19","author":"Morrison","year":"2009","journal-title":"Trends Cell Biol."},{"issue":"2","key":"2020090103122322100_CIT0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drudis.2015.09.012","article-title":"The role of the 14-3-3 protein family in health, disease, and drug development","volume":"21","author":"Aghazadeh","year":"2016","journal-title":"Drug Discov Today."},{"issue":"4","key":"2020090103122322100_CIT0026","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF02339012","article-title":"Molecular evolution of the 14-3-3 protein family","volume":"43","author":"Wang","year":"1996","journal-title":"J Mol Evol."},{"issue":"12","key":"2020090103122322100_CIT0027","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0968-0004(92)90339-B","article-title":"14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins","volume":"17","author":"Aitken","year":"1992","journal-title":"Trends Biochem Sci."},{"issue":"11","key":"2020090103122322100_CIT0028","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.3899\/jrheum.131446","article-title":"Serum 14-3-3\u03b7 is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis","volume":"41","author":"Maksymowych","year":"2014","journal-title":"J Rheumatol."},{"issue":"11","key":"2020090103122322100_CIT0029","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s10067-017-3807-2","article-title":"Elevated serum 14-3-3\u03b7 protein may be helpful for diagnosis of early rheumatoid arthritis associated with secondary osteoporosis in Chinese population","volume":"36","author":"Gong","year":"2017","journal-title":"Clin Rheumatol."},{"issue":"7","key":"2020090103122322100_CIT0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/bmm-2017-0371","article-title":"Clinical significance of detecting HLA-DR, 14-3-3\u03b7 protein and d-dimer in the diagnosis of rheumatoid arthritis","volume":"12","author":"Tan","year":"2018","journal-title":"Biomark Med."},{"issue":"4","key":"2020090103122322100_CIT0031","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000369899","article-title":"Anti-CCP antibodies and rheumatological findings in Brazilian patients with Crohn\u2019s disease","volume":"91","author":"Mocelin","year":"2015","journal-title":"Digestion."},{"issue":"2","key":"2020090103122322100_CIT0032","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.semarthrit.2017.04.009","article-title":"The 2010 ACR\/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: results from the Leiden-EAC and ESPOIR cohorts","volume":"47","author":"Boeters","year":"2017","journal-title":"Semin Arthritis Rheum."},{"key":"2020090103122322100_CIT0033","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13075-016-0935-z","article-title":"Serum levels of 14-3-3\u03b7 protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis","volume":"18","author":"Carrier","year":"2016","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"2020090103122322100_CIT0034","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/1756-185X.12434","article-title":"Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients","volume":"19","author":"Galil","year":"2016","journal-title":"Int J Rheum Dis."},{"key":"2020090103122322100_CIT0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13075-015-0803-2","article-title":"Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study","volume":"17","author":"Ma","year":"2015","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"2020090103122322100_CIT0036","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/rheumatology\/keg037","article-title":"Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis","volume":"42","author":"Green","year":"2003","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"2020090103122322100_CIT0037","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13075-017-1403-0","article-title":"Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year","volume":"19","author":"Ziegelasch","year":"2017","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"2020090103122322100_CIT0038","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14397595.2016.1265907","article-title":"Autoimmunity as a trigger for structural bone damage in rheumatoid arthritis","volume":"27","author":"Schett","year":"2017","journal-title":"Mod Rheumatol."},{"issue":"10","key":"2020090103122322100_CIT0039","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","article-title":"Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis","volume":"54","author":"Van Staa","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"2020090103122322100_CIT0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","article-title":"Bone turnover markers in the diagnosis and monitoring of metabolic bone disease","volume":"63","author":"Greenblatt","year":"2017","journal-title":"Clin Chem."},{"issue":"10","key":"2020090103122322100_CIT0041","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/rheumatology\/kev410","article-title":"Novel biological markers of bone: from bone metabolism to bone physiology","volume":"55","author":"Chapurlat","year":"2016","journal-title":"Rheumatology (Oxford)."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/labmed\/article-pdf\/51\/5\/529\/33702935\/lmaa001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/labmed\/article-pdf\/51\/5\/529\/33702935\/lmaa001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T07:13:19Z","timestamp":1598944399000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/51\/5\/529\/5741796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,2,20]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmaa001","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,2,20]]}}}